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In the classification of acute leukemias, the nuclear enzyme terminal deoxy-
nucleotidyl transferase (TdT)' is a marker commonly used to differentiate
between the lymphoid or myeloid origin of the neoplastic clone . Common, T,
and null acute lymphoblastilc leukemias (ALL) are characteristically TdT''', re-
flecting the proliferation of immature lymphoid cells, while TdT is usually
negative in acute myeloid leukemia (AML) . However, it is well documented that
a small proportion (5-10%) ofAML are TdT' (l, 2). The explanation for this
unexpected, though consistent finding, has remained uncertain .
The analysis of DNA rearrangements at the Ig and T cell receptor (TCR)
chain regions has proved a valuable approach toward a more accurate definition
of the cell lineage, clonal origin, and stage of differentiation of acute and chronic
B and T lymphoid leukemias (3-12) . In the same way, the T cell rearranging y
gene (TRG-y) is an indicator of clonal proliferation characteristic of human T
cells since in all forms ofT cell leukemia so far reported, a TRG-y rearrangement
occurs (13-15) .
To better characterize the distinctive features between TdT- and TdT'' AML,
and possibly to define the cell lineage of the latter cases, we have studied at the
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ALL, acute lymphoblastic leukemia ; AML, acute myeloblastic
leukemia ; EM, electron microscopy ; TdT, terminal deoxynucleotidyl transferase ; TCR, T cell
receptor; TRG, T cell rearranging gene ; WBC, white blood cells .
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molecular level a series of 52 AML, 10 of which were TdT'. The leukemic
population was typed for markers ofDNA rearrangements both at the H (Igh)
and L (IgK, Igl) chain Ig genes, the TCR-ß chain locus, and theTRG - 'y region .
A highly significant correlation between TdT expression and DNA rearrange-
at the Igh locus was found ; 8 of the 10 TdT' AML carried new conigu-
at the Igh region, while this occurred only in 2 of 42 TdT- cases .
Furthermore, clear or suggestive signs ofTCR-,8 and/orTRG-y gene rearrange-
ment appeared restricted to the TdT+, Igh-rearranged group . These findings
suggest that most TdT' AML appear characterized by the expansion of a very
early cell population molecularly committed along the lymphoid differentiation
pathway, irrespective of the persistent expression of myeloid-related features .
Materials and Methods
Patient Population.
￿
52 AML patients were included in the study, including 10 TdT'
AML patients. The diagnosis of AML was based on morphological and cytochemical
iteria ; myeloperoxidase was assessed in all cases with light microscopy, and in twoTdT'
(patients 5 and 8), also with electron microscopy (EM). Diagnosis was also based on
absence o£-the common ALL-associated antigen, as well as other B (OKB2, BA 1, B1)
and T (Leu9, T1, T11, T6, T3, T4, T8) cell-related markers (except for patient 6, see
below, who showed a biphenotypic picture), and/or, in the TdT' cases, also on the
expression of one or more antigens recognized by anti-myeloid mAbs. For this latter
purpose the following reagents were used (partly commercial and partly obtained from
the 2nd International Workshop, Boston, MA, 1984) : My4, My7, My9 (Coulter Immu-
nology, Hialeah, FL), Mo5 (16), NHL30.5 (17), LeuMI (Becton Dickinson & Co .,
Sunnyvale, CA), UCHM1 (Techno Genetics, Torino, Italy), MG1 (Techno Genetics),
OKM1 (Ortho Diagnostic Systems, Inc ., Westwood, MA), anti-lysozyme antiserum (mur-
amidase ; Dako Corp ., Copenhagen, Denmark) . All immunological characterizations were
carried out on the bone marrow or, less frequently, on the peripheral blood leukemic
population after fractionation on a Lymphoprep (Nyegaard A/C, Oslo, Norway) gradient .
The indirect immunofluorescence technique used has been described in detail elsewhere
(18) . For nuclear TdT, cytocentrifuge spreads were fixed in cold methanol for 30 min,
tranferred to cold PBS for 30 min, and stained using a rabbit anti-TdT and, as a second
layer, a FITC-F(ab')2 goat anti-rabbit IgG (both purchased from Bethesda Research
Laboratories, Gaithersburg, MD) . The myeloid affiliation of the 10 TdT' patients and
the clinical outcome of each patient were as follows .
Patient 1 .
￿
A 9-yr-old girl with a white blood cell (WBC) count of 3.99 x 10'° per liter
was classified as M I according to the FAB classification . The blasts were myeloperoxidase-
positive (48%) and 89% expressed the OKM1 antigen ; 52% were TdT+ . The patient
went into complete remission with an anti-myeloid protocol, but relapsed after 8 mo . She
underwent an allogeneic bone marrow transplantation, which was followed by a second
marrow relapse 7 mo later . The child was then refractory to treatment and died 5 mo
later.
Patient 2 .
￿
A 45-yr-old woman with a WBC count of 6 x 109 per liter was classified as
M5 . 52% of the blasts were muramidase-positive ; 45 and 40% expressed the My9 and
My7 antigens, respectively, while 80% were TdT' . She was treated with an anti-myeloid
regimen and she died during induction .
Patient 3.
￿
A 3-mo-old girl with a WBC count of 6.5 X 10" per liter was classified as
M5 . 2% of the blasts were myeloperoxidase-positive; 70% were recognized by My9, 65%
by NHL30.5, 70% by UCHM1, and 69% by Mo5 . TdT was positive in 72% of the
elements. A partial remission was obtained after 14 mo of treatment with anti-myeloid
and anti-lymphoid cytotoxic agents . I mo later the child showed a complete relapse .
Patient 4 .
￿
A 12-yr-old girl with a WBC count of 1 .1 x 10'° per liter was classified as
MI . 40% of the blasts reacted with LeuM1, 30% with NHL30.5, 62% with Mo5, and
23% with UCHMI . TdT was positive in 18% of the blasts . Double labeling showed thatFOA ET AL.
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TdT' cells were also Mo5+. Complete remission was obtained with Vincristine, Adria-
mycin, and Prednisone. 11 mo later, however, the child relapsed.
Patient 5.
￿
A 2-mo-old girl with a WBC count of 1 .1 X 10'2 per liter was classified as
M5 . 2% of the blasts were myeloperoxidase-positive as shown by light microscopy; this
was further confirmed by EM. 66% of the blasts were positive for My7, 50% for My9,
69% for Mo5, and 74% for LeuM 1 . 71 % ofthe elements were TdT+. Despite the rotation
of different cytotoxic agents the child died without achieving a complete remission.
Patient 6.
￿
A 13-yr-old girl with a WBC count of 1 .98 X 10 1 ` per liter was classified as
L1 (50%)/M5 (50%). This patient showed a biphenotypic picture: one myeloid, docu-
mented by the reactivity with My9 (41%) and MG1 (48%), and one lymphoid, according
to the expression ofJ5 (common ALL antigen; 45%), OKB2 (44%), and BA 1 (41%). 90%
of the elements (both myeloid and lymphoid) were TdT+. The child was refractory to all
forms of treatment and died without obtaining a complete remission.
Patient 7.
￿
A 41-yr-old man with a WBC count of 2.1 X 10 1° per liter was classified as
M4. Myeloperoxidase was positive in 40% of the blasts and nonspecific esterase in 90% .
95% of the elements were TdT+. The patient, treated with Adriamycin, Ara-C, 6-
Thioguanine, and Vincristine was in complete remission 18 mo after diagnosis.
Patient 8.
￿
A 4-yr-old boy with a WBC count of 2 X 10' 1 per liter was classifiedas M5.
The blasts were myeloperoxidase-positive as shown by EM, and 20% were muramidase-
positive, 80% My9', and 79% My4+. 80% ofthe elements were TdT+. Complete remission
was achieved after 1 yr of combined chemotherapy with anti-lymphoid and anti-myeloid
agents. He then underwent an autotransplant, but relapsed soon after.
Patient 9.
￿
An 8-yr-old girl with a WBC count of 4 X 101° per liter was classified as
M1 . 54% of the blasts were myeloperoxidase-positive, 36% were OKM1 +, and 38% were
recognized by My7. 26% of the elements were TdT+. Double labeling suggested that
TdT was not present on the myeloperoxidase-positive cells. The child was induced with
an anti-myeloid regimen, was in remission for 2 mo, then relapsed and died.
Patient 10.
￿
A 7-yr-old girl with a WBC count of 2 X 10 1° per liter was classified as
MI . 25% of the blasts were myeloperoxidase-positive, 9% were My9+, and 15% reacted
with OKM1 . 25% of the elements were TdT'. Double labeling showed that myeloper-
oxidase-positive cells were TdT-. The child, treated with an anti-myeloid protocol, died
during induction.
DNA Analysis. High molecular weight DNA was extracted from the leukemic cell
population separated as described above. After digestion with the appropriate restriction
enzymes (see legend to Table I) and electrophoresis on 0.8-0.6% agarose gel, DNA was
blotted on nitrocellulose paper and hybridized to 12P nick-translated probes as already
described (4). The Igh, Igrc, Iga, TCR-0, and TRG-y regions were examined by means of
the following probes: Igh, 3.3-kb Eco RI-Hind III fragment containing the 3' half of the
Igh joining (J) elements (19); IgK, 2.7-kb Eco RI fragment isolated from the recombinant
phage Huk (20), carrying the region coding for the constant domain of the K light chain
gene (Clc); IgX, 1 .2-kb Barn HI fragment derived from the recombinant phage Hua5 (21),
containing the constant Ca2 gene that encodes the Kern-, Oz isotype; TCR-0, 400-bp
Bgl II cDNA fragment derived from JUR-02 clone (22) coding for most of the C#2
constant domains; TRG-,y, 700-bp Hind III-Eco RI genomic fragment containing the
joining Qyl) region, ahead of the C71 segment (23). The latter three probes hybridize
equally well to the other highly homologous members of their gene families (i.e., to CX1
and CX3-9, Cf 1, and TRG J72, respectively). The maps of all these gene regions have
been reported in detail in the above cited references.
Results
Ig Gene Analysis.
￿
In 8 of 10 TdT' AML a rearrangement of the Igh gene
region was found (Fig. 1, Table I) . In one of the latter cases (Table I, patient 2),
a reorganization of the K light chain was also documented (Fig. 2). The two
germline TdT' AML (Table I, patients 9 and 10) showed relatively low per-882 GENE REARRANGEMENTS IN ACUTEFOA ET AL.
TABLE I
Analysis at the Igh, Iga, IgX, TCR-,B, and TRG-y Gene Loci in 10 TdT+ and 2
Rearranged TdT- AML
Ight
￿
IgX
￿
TRG-yl
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'" Myeloperoxidase at light microscopy.
G, germline; R, rearranged; r, rearranged fragments of faint intensity.
Only restriction enzyme Bam HI used.
l A tentative assignment ofthe TRGy "genotype" differentiating between Cyl and Cy2 gene involvementis shown: Cyl "genotype" is shown
on the left side of the shill, and Cy2 on the right. The three Rs added to the G/G TRGy genotype of patient 7 indicate that three
conspicuous, rearranged fragmentswere found over an apparently typical germline background (see Fig. 8 and text for details).
The 90% TdT expression and the absence of a germline Igh fragment suggest that the apparent biphenotypic population (myeloid and
lymphoid, see Results) are most likely derived from acommon precursor.
"> Patient 11 was classified as M 1; in addition to myeloperoxidase, the leukemic cells were also sudan black-positive, and negative for B and
T lymphoid markers.
# Patient 12 was classifiedas M4; 20% ofthe elements were naphthyl acetate esterase-positive; 10% also showed nonspecific esterase positivity
(sensitive to sodium fluoride). 80% and 10% of the blasts were MGl* and OKMI*, respectively, while they were negative for B and T
lymphoid markers.
centages ofTdT+ cells (26% and 25%). Double staining indicated that TdT was
in fact not expressed on the blasts carrying myeloid markers.
40 of the 42 TdT- AML showed the expected germline configuration of the
Igh region. The two patients that carried a J rearrangement also showed a
reorganization of the K light chain gene. The difference in the incidence of JH
rearrangements betweenTdT+and TdT- AML wasstatistically highly significant
(p = 2.5 X 10-6). Whenever possible, the rearranged configurations were
confirmed with different restriction enzymes to rule out polymorphisms (see
Table I). Possible evidence ofthe latter phenomenon was observed only with the
Patient TdT MPO' Configura-
Lion
Restriction
enzyme used
Igxf Configu-
ration
Restriction
enzyme
used
TCR-0 Configura-
tion
Restriction
enzyme used
1 52 48 Grr BgI II G - - GR GR/G Barn HI, Eco RI
2 80 0 RR BgI 11, Eco RI GR - - G G/G Bam HI, Eco RI
8 72 2 RR BgI 11 G - - G G/G Barn HI, Eco RI
4 18 0 RR BgI 11 G - - G G/G Ram HI, Eco RI
5 71 2 RRr BgI 11, Sac I G - - G G/G + r Barn HI, Eco RI,
Sac I
6s 90 0 RR Sac I, Hind III G - - G G/G Barn HI, Sac 1,
Hind III
7 95 40 RR Eco RI, Sac I - - - - G/G + RRR Eco RI
8 80 0 GRR BgI II G - - G GR/G Bam HI, Eco RI
9 26 54 G BgI 11, Bam HI, G G Eco RI, G G/G Bam HI, Eco RI
Eco RI, Sac 1, Hind 111
Pst 1, Hind Ill
10 25 25 G BgI II, Barn HI, G G Eco RI G G/G Bam Hl, Eco RI
Pst 1, Hind III
11+" 0 80 GR BgI 11, Eco RI, GR G Eco RI - G/G Eco RI
Sac I, Pst I
124 0 0 GR Barn HI, Eco RI, GR G Eco RI, G G/G Bam HI, Eco RI
Sac 1, Hind III Hind III884
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FIGURE 2 .
￿
Southern blot analysis of the three AML (patients 2, 11, and 12) exhibiting a Cu
rearrangement . In all cases, Barn HI restriction enzyme was used . The sizes in kilobase of
germline (asterisks) and rearranged (arrows) bands are indicated . C, control DNA.
J probe in patients 9 and 11 . These two patients showed a discordant pattern
respectively with one of the six (Hind III) and one of the four (Bgl II) restriction
enzymes used . All together, 10 of the 52 AML tested with the J,' probe and 3 of
the 46AML studied with the Cx probe presented a novelDNA configuration at
the respective loci (Table I) . However, an atypical rearranged pattern was
observed in 3 of the 10 above-mentioned patients, i.e ., more than the two
expected J-hybridizing fragments were found in patients 1, 5, and 8 (see Fig.
1) . No IgXgene rearrangement couldbe identifiedamongthe 26 samplesstudied,
including two with a Ca rearrangement .
TCR-,O andTRG-y Gene Analysis .
￿
The TCR-(3 and TRG-y loci were analyzed
in 47 and 51 patients, respectively . While the great majority of samples showed
no signs of TCR gene rearrangement, four patients (1, 5, 7, and 8) presented
suggestive evidence of TCR-a and/or TRG-y gene involvement . The pattern of
gene rearrangement varied markedly among these four patients, either in the
number or in the intensity of the novel bands . The novel Barn HI and Eco RI
fragments detected by the TRG-y probe had the expected size of the most
common Vy gene-containing segments (14, 15, and our unpublished observa-
tions) and did not fit with an incomplete digestion pattern . Indeed, an apparently
typical clonal pattern of rearrangement could be recognized in patients 1 and 8,
in whom either both TCR-/3 and TRG-y or TRG-y only were respectively
involved . In these two samples, the novel rearranged fragments gave a hybridi-
zation signal not dissimilar to the one shown by the unrearranged counterparts
(Fig . 3) . In the two remaining samples, the rearranged bands appeared too faint
(patient 5) or there were too many (patient 7) to account fora clonal involvement
of the entire neoplastic cell population . All four patients with true or accessoryFOA ET AL .
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FIGURE 3 .
￿
TCR-S and TRG-y gene configuration, after Southern blot hybridization with
the respective probes, of four rearranged TdT* AML (patients 1, 5, 7, and 8). (C) contain
unrearranged control DNA . The two TCR-,8 constant genes, C#1 and C#2, are both located
within the 24-kb BamHI germline fragment; the two J, gene segments,JyI andJy2, migrate
on different fragments after Bam HI, Sac I, and Eco RI digestion, i . e ., the Jyl on the 20-,
6.4-, and 1 .55-kb ; theJy2 on the 13-, 7.0-, and 3.2-kb fragment, respectively (13, 23, andour
unpublished observations). In patient 1, the reduced signal of the higher molecular weight
bands can be ascribed to partial DNA degradation . The TRG-y pattern of the latter case
showsan intensity ratiobetween the novel 11 .2- and the 13-kb germline band of ^-0.5, which
is consistent with a germline configuration at both Cy2 gene regions . Whethera second Cyl
allele is or is not rearranged can not be clearly established because of the just-mentioned
partial degradation of the higher molecular weight fragments . However, the presence of a
residual signal at the 20-kb germline position seems to favor the involvement of only one Cy1
allele.
signs of TCR-,B or TRG-y gene rearrangement were encountered among theJ-
rearranged TdT+ AML.
Discussion
The cell origin of the rare cases of TdT+ AML has remained a matter of
debate . This issue, along with the biological implications related to the signifi-
cance of the inappropriate expression ofTdT in apparently myeloid blasts, has
clinical relevance, especially in view of the overall badprognoses of these patients
and their poor response to treatment (2). The enzyme TdT, associated with the
early stages of normal and malignant T and B cell differentiation, is found in
bone marrow and thymus lymphoid cells, as well as in T, common, and null ALL886
￿
GENE REARRANGEMENTS IN ACUTE MYELOID LEUKEMIA
(1); on the other hand, TdT is absent in the great majority of AML (1, 2), thus
representing a valuable and widely exploited diagnostic marker between lymph-
oid and myeloid acute leukemias. Functionally, this enzyme catalyzes the polym-
erization of deoxynucleotides on the 3'-hydroxyl terminus ofan oligonucleotide
primer in the absence of a template (24). Although its function during the
ontogeny of the lymphoid lineage is not yet clear, it has been suggested that it
may have an ancillary role in the DJH or V-DJ,, recombination (25). Studies of
murine pre-B cell lines transformed by Abelson murine leukemia virus (26, 27)
are consistent with the suggestion that the enzyme may be responsible for the
addition of extra nucleotides (the so-called N regions) at the junctions of V, D,
andJ segments.
In this study, we have analyzed the DNA configuration at the Ig H and L,
TCR-fl, and TRG-y loci in a group of52 patients with AML, which included 10
TdT' cases. The myeloid affiliation ofthe TdT' cases was based on morpholog-
ical, cytochemical, and immunological features (myeloperoxidase positivity
and/or expression of one or more myeloid-associated antigens), together with
the absence of B and T cell-related markers. Our data show a significant
correlation between Igh rearrangement and TdT expression. 8 of the 10 J,
rearranged cases belonged in fact to the TdT' group, while only 2 of the 42
TdT- cases showed evidence ofJ,, rearrangement (p = 2.5 x 10-6). This latter
finding confirms that an Igh involvement in classical TdT- AML is indeed a
very rare event (28-30).
A reorganization ofthe IgK region could also be demonstrated in 3 of the 46
AML tested (1 TdT' and 2 TdT-). As expected, in all three the Igh locus was
also rearranged. Thus, it appears that the rare Ig rearrangements observed in
non-B leukemias are not confined only to the Igh locus but may also take place
at the K L chaingene region, the involvement ofwhich is conventionallyassociated
with a more mature level ofdifferentiation.
The data obtained with the TCR-,Q and TRG-y DNA probes show that these
loci may be rearranged in AML (4 of 52; patients 1, 5, 7, and 8), the rearrange-
ments being in all cases restricted to the TdT' subgroup carrying a novel JH
configuration. While in patients 1 and 8 the TCR-a and/or TRG-'r gene orga-
nization points to a typical monoclonal pattern, in the remaining two the TRG-
y novel fragments appeared too faint (patient 5) or there were too many (patient
7) to be compatible with a monoclonal situation. It is of interest that a similar
heterogeneity, both in number and intensity of rearranged fragments, was also
observed after analysis with theJH probe in three of the above four mentioned
patients (No. 1, 5, and 8). The coexistence in patients 1 and 8 of three J,,-
containing fragments, one of which is germline (with only one chromosome
rearranged at the TCR-,8 and/or TRG-y loci), may have different explanations.
A trisomy of chromosome 14, a J,, duplication due to unequal chromatid
exchanges, or a mixture of two cell populations, one carrying the B and one the
T markers of rearrangement, may account for these findings. Even in the case
of the latter possibility, i.e., biclonality, myeloid markers would be present on
both these cell populations (see Results). In the other two samples with both Igh
and TRG-y clonal markers (patients 5 and 7), the absence of any germline J,
containing bands implies the existence of a clone(s) carrying both regions rear-FOA ET AL.
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ranged within the same cell. Again, aneuploidy or unequal sister chromatide
exchange may be responsible for the additional rearranged bands. Should this
be the case, the hypothesis of oligoclonality would be questionable, while the
concept ofa concomitant involvement within a single cell of the Igh and TRG-
y loci would still hold.
Can these findings help to unravel the apparently conflicting TdT expression
in leukemic blasts exhibiting myeloid features? The highly significantcorrelation
between TdT positivity and Igh rearrangement reported here supports the view
that the expression of the enzyme TdT may indeed by coupled to the activity of
the V-(D)J-specific recombinase/s (25-27). The evidence that both Igh and
TRG-y rearrangements positively correlate with TdT expression favors the
concept that a unique enzymatic machinery might be involved in the rearrange-
ment ofthese B and Tcell-specific loci (27).
This study suggests a predominant lymphoid commitment ofTdT' AML. The
pattern of genomic configuration, i.e.,J,, gene rearrangement sometimes associ-
ated with a TCR-(3 and/or TRG-y gene reorganization, is similar to that found
in non-T-ALL (12, 31 and our unpublished observations) and seems therefore
to point to a B cell affiliation for most of these cases. It is conceivable that in
these patients the target of the leukemic event is represented by a very early
TdT+ progenitor cell that is molecularly and not yet phenotypically B lineage
oriented, but that is also capable of expressing some myeloid-related features,
possibly due to a transient lineage spill-over before reaching a more restricted
lymphoid expression . These findings suggest that the expression of TdT in
apparently myeloid blasts does not appear due to the expression of abnormal
differentiation (lineage infidelity) (32). As suggested by Greaves et al. (33), we
favor the hypothesis that in the normal process of early hemopoietic differentia-
tion, a certain degree ofpromiscuity may occur so that some markers, normally
restricted to different cell lineages, may be transiently coexpressed. This is
further confirmed by patient 6, who showed an Igh rearrangement with no
evidence of germline bands (and 90% TdT positivity), despite a clear bipheno-
typic pattern (myeloid and lymphoid), and by patient 8, who recently relapsed,
and who expressed B cell-related antigens, having lost all myeloid features (our
unpublished data). While in most TdT+ JH-rearranged AML the expression of
myeloid markers may be a temporary event retained by lymphoid committed
blasts, in the two germline TdT+ patients, the lack of clonal markers points to
the highly immature stage ofcell differentiation, such that a firm conclusion on
the cell origin of these proliferations can not be reached.
Finally, the heterogenous phenotypic and molecular potential ofthe leukemic
population documented by this study may lead to an understanding of the
difficulties in the treatment of these patients, and their frequent refractiveness
to the commonly used cytotoxic agents.
Summary
The cell origin of the rare terminal deoxynucleotidyl transferase (TdT)-
positive acute myeloid leukemias (AML) was investigated at the molecular level,
by examining the configuration of the Ig H (Igh) and L (IgK, IgX) chain gene
regions, and ofthe Tcell receptor (TCR) 0 and Tcell rearranging (TRG) y loci.888
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In 8 of the 10 TdT+ AML analyzed (classified as myeloid according to morpho-
logical and cytochemical criteria, and to the reactivity with one or more anti-
myeloid mAbs), a rearrangement of the Igh chain gene was found. In TdT-
AML, evidence of an Igh gene reorganization was instead observed only in 2 of
the 42 patients studied . Furthermore, evidence of TCR-,B and/or TRG-y gene
rearrangement was observed in four AML, all of which belonged to the Igh-
rearranged TdT' group. In three cases (one TdT+ and two TdT-), the IgK L
chain gene was also in a rearranged position. These findings demonstrate a
highly significant correlation between TdT expression and DNA rearrangements
at the Igh and TCR chain gene regions and support the view that this enzyme
plays an important role in the V-(D)J recombination machinery. Overall, the
genomic configuration, i.e., JH gene rearrangement sometimes coupled to a K L
chain and TCR gene reorganization, similar to that found in non-T-ALL,
suggests that in most cases of TdT+ AML, the neoplastic clone, despite the
expression of myeloid-related features, is characterized by cells molecularly
committed along the B cell lineage.
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